BioNexus Gene Lab (BGLC) said Wednesday its board has approved its Ethereum-focused treasury strategy, prioritizing Ethereum as a strategic treasury asset.
The company said Ethereum presents a strategic treasury management solution due partly to its institutional credibility and yield-generation capabilities.